Income Tax Expense (Benefit) of BIO-RAD LABORATORIES, INC. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
BIO-RAD LABORATORIES, INC. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2025 was $209,200,000.
  • BIO-RAD LABORATORIES, INC. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2025 was $235,600,000.
  • BIO-RAD LABORATORIES, INC. annual Income Tax Expense (Benefit) for 2025 was $235,600,000.
  • BIO-RAD LABORATORIES, INC. annual Income Tax Expense (Benefit) for 2024 was $498,300,000, a 134% decline from 2023.
  • BIO-RAD LABORATORIES, INC. annual Income Tax Expense (Benefit) for 2023 was $212,800,000, a 80% increase from 2022.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $235,600,000 $209,200,000 +$402,300,000 01 Oct 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $166,700,000 $89,200,000 -$297,600,000 -143% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $130,900,000 $96,200,000 +$717,000,000 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $586,100,000 $19,400,000 -$87,800,000 -82% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $498,300,000 $193,100,000 -$271,764,000 -345% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $226,536,000 $208,400,000 +$177,555,000 +576% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $404,091,000 $620,800,000 -$282,624,000 -84% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $121,467,000 $107,200,000 +$91,333,000 +576% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $212,800,000 $78,664,000 -$184,922,000 -70% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
Q3 2023 $27,878,000 $30,845,000 +$75,355,000 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $103,233,000 $338,176,000 -$43,085,000 -15% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $60,148,000 $15,867,000 +$1,016,552,000 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $1,076,700,000 $263,586,000 +$725,431,000 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $1,802,131,000 $44,510,000 -$1,138,703,000 -104% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $663,428,000 $295,091,000 -$537,752,000 -222% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $125,676,000 $1,000,685,000 -$1,320,474,000 -413% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $1,194,798,000 $461,845,000 -$703,683,000 -291% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
Q3 2021 $1,898,481,000 $1,094,193,000 +$724,556,000 +196% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $1,173,925,000 $242,661,000 -$36,855,000 -13% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022 2022 Q2
Q1 2021 $1,210,780,000 $319,789,000 +$107,002,000 +50% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $1,103,778,000 $241,838,000 +$95,894,000 +66% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
Q3 2020 $1,007,884,000 $369,637,000 +$446,037,000 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $561,847,000 $279,516,000 +$108,725,000 +64% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $453,122,000 $212,787,000 -$49,284,000 -19% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $502,406,000 $145,944,000 +$358,662,000 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
Q3 2019 $143,744,000 $76,400,000 -$157,205,000 -195% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 $300,949,000 $170,791,000 +$98,748,000 +137% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $202,201,000 $262,071,000 +$55,156,000 +27% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $147,045,000 $212,718,000 -$175,918,000 -478% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 $322,963,000 $80,805,000 +$72,284,000 +848% 01 Jul 2018 30 Sep 2018 10-Q 01 Nov 2019 2019 Q3
Q2 2018 $250,679,000 $72,043,000 +$75,958,000 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $174,721,000 $206,915,000 +$199,181,000 +2575% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $24,460,000 $36,800,000 -$27,300,000 -287% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2018 2017 FY
Q3 2017 $2,840,000 $8,521,000 +$2,921,000 +52% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 $81,000 $3,915,000 -$14,215,000 -138% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $14,134,000 $7,734,000 -$1,466,000 -16% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $15,600,000 $9,500,000 -$18,070,000 -211% 01 Oct 2016 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $33,670,000 $5,600,000 -$2,445,000 -30% 01 Jul 2016 30 Sep 2016 10-K 16 Apr 2018 2017 FY
Q2 2016 $36,115,000 $10,300,000 -$817,000 -7.3% 01 Apr 2016 30 Jun 2016 10-K 16 Apr 2018 2017 FY
Q1 2016 $36,932,000 $9,200,000 +$324,000 +3.6% 01 Jan 2016 31 Mar 2016 10-K 16 Apr 2018 2017 FY
Q4 2015 $36,608,000 $8,570,000 +$1,861,000 +28% 01 Oct 2015 31 Dec 2015 10-K 16 Apr 2018 2017 FY
Q3 2015 $34,747,000 $8,045,000 -$2,922,000 -27% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 $37,669,000 $11,117,000 -$6,049,000 -35% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $43,718,000 $8,876,000 +$1,006,000 +13% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q4 2014 $42,712,000 $6,709,000 -$7,665,000 -53% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $50,377,000 $10,967,000 +$9,084,000 +482% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $41,293,000 $17,166,000 +$2,724,000 +19% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $38,569,000 $7,870,000 +$3,995,000 +103% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q4 2013 $34,574,000 $14,374,000 -$4,915,000 -25% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $39,489,000 $1,883,000 -$10,500,000 -85% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $49,989,000 $14,442,000 -$3,012,000 -17% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2014 Q2
Q1 2013 $53,001,000 $3,875,000 -$11,360,000 -75% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $64,361,000 $19,289,000 -$4,714,000 -20% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $69,075,000 $12,383,000 +$2,472,000 +25% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $66,603,000 $17,454,000 -$343,000 -1.9% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $66,946,000 $15,235,000 -$88,000 -0.57% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q4 2011 $67,034,000 $24,003,000 +$34,739,000 01 Oct 2011 31 Dec 2011 10-K 18 Mar 2014 2013 FY
Q3 2011 $32,295,000 $9,911,000 -$2,913,000 -23% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $35,208,000 $17,797,000 +$964,000 +5.7% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q1 2011 $34,244,000 $15,323,000 +$896,000 +6.2% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q4 2010 $33,348,000 $10,736,000 01 Oct 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY
Q3 2010 $12,824,000 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 $16,833,000 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011 2011 Q2
Q1 2010 $14,427,000 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011 2011 Q1

BIO-RAD LABORATORIES, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $235,600,000 +$733,900,000 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 $498,300,000 -$285,500,000 -134% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 $212,800,000 +$863,900,000 +80% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 $1,076,700,000 -$2,271,498,000 -190% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $1,194,798,000 +$91,020,000 +8.2% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $1,103,778,000 +$601,372,000 +120% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $502,406,000 +$355,361,000 +242% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
2018 $147,045,000 +$171,489,000 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $24,444,000 -$40,004,000 -257% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $15,560,000 -$21,048,000 -57% 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019 2018 FY
2015 $36,608,000 -$6,104,000 -14% 01 Jan 2015 31 Dec 2015 10-K 16 Apr 2018 2017 FY
2014 $42,712,000 +$8,138,000 +24% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $34,574,000 -$29,787,000 -46% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $64,361,000 -$2,673,000 -4% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $67,034,000 +$33,686,000 +101% 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2014 2013 FY
2010 $33,348,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.